Estetrol Prevents Hot Flushes and Improves Quality of Life in Patients with Advanced Prostate Cancer Treated with Androgen Deprivation Therapy: The PCombi Study

BACKGROUND: Androgen deprivation therapy (ADT) for prostate cancer (PCa) is accompanied by side effects affecting health-related quality of life (HRQL). OBJECTIVE: To assess the effects of the fetal estrogen estetrol (E4) on symptoms related to estrogen and androgen deficiency, and on HRQL measured...

Descripción completa

Detalles Bibliográficos
Autores principales: Zimmerman, Yvette, Frydenberg, Mark, van Poppel, Hendrik, van Moorselaar, R. Jeroen A., Roos, Erik P.M., Somford, Diederik M., Roeleveld, Ton A., de Haan, Tjard D., van Melick, Harm H.E., Reisman, Yacov, Krijgh, Jan, Debruyne, Frans M.J., Coelingh Bennink, Herjan J.T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Prostate Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637725/
https://www.ncbi.nlm.nih.gov/pubmed/36353657
http://dx.doi.org/10.1016/j.euros.2022.09.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637725/
https://www.ncbi.nlm.nih.gov/pubmed/36353657
http://dx.doi.org/10.1016/j.euros.2022.09.006

Ejemplares similares